Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | MGAM | O43451 | 1/20 | 0.52 |
| ▸ | SI | P14410 | 1/20 | 0.52 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | MMP8 | P22894 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | GSK3A | P49840 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL630893 | 0.75 | GAA (0.46) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL435045 | 0.74 | GAA (0.57) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL631915 | 0.74 | GAA (0.57) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL2821 | 0.73 | — | — | |
| SCHEMBL13643227 | 0.73 | GAA (0.50) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL17792657 | 0.73 | GAA (0.50) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL1245716 | 0.73 | GAA (0.50) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL4846715 | 0.73 | — | — | |
| SCHEMBL230795 | 0.73 | MGAM (0.50) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL7405660 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016051315-A1 | ZIEGLER-NATTA CATALYST SYSTEM AND USE THEREOF | RELIANCE INDUSTRIES LIMITED (IN) | 2016-04-07 | — | — | WO | claimed |
| US-8247341-B2 | Procatalyst composition with silyl glutarate and method | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-08-21 | — | — | US | claimed |
| US-20100267911-A1 | Procatalyst Composition with Silyl Glutarate and Method | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-10-21 | — | — | US | claimed |
| US-10344103-B2 | Ziegler-Natta catalyst composition for preparing polyethylene | RELIANCE INDUSTRIES LIMITED (IN) | 2019-07-09 | — | — | US | disclosed |
| US-20170306061-A1 | Ziegler-Natta Catalyst Composition for Preparing Polyethylene | RELIANCE INDUSTRIES LIMITED (IN) | 2017-10-26 | — | — | US | disclosed |
| EP-3191531-A2 | A ZIEGLER-NATTA CATALYST COMPOSITION FOR PREPARING POLYEHTYLENE | Reliance Industries Limited (IN) | 2017-07-19 | — | — | EP | disclosed |
| WO-2016051315-A1 | ZIEGLER-NATTA CATALYST SYSTEM AND USE THEREOF | RELIANCE INDUSTRIES LIMITED (IN) | 2016-04-07 | — | — | WO | disclosed |
| US-8247341-B2 | Procatalyst composition with silyl glutarate and method | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-08-21 | — | — | US | disclosed |
| US-8247341-B2 | Procatalyst composition with silyl glutarate and method | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-08-21 | — | — | US | disclosed |
| EP-2419458-A1 | PROCATALYST COMPOSITION WITH SILYL GLUTARATE AND METHOD | Dow Global Technologies LLC (US) | 2012-02-22 | — | — | EP | disclosed |
| US-20100267911-A1 | Procatalyst Composition with Silyl Glutarate and Method | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-10-21 | — | — | US | disclosed |
| US-20100267911-A1 | Procatalyst Composition with Silyl Glutarate and Method | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-10-21 | — | — | US | disclosed |
| WO-2010120973-A1 | PROCATALYST COMPOSITION WITH SILYL GLUTARATE AND METHOD | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-10-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100267911-A1 | Procatalyst Composition with Silyl Glutarate and Method | MPST, TST, TKT | GAA 282/4885MGAM 689/4885SI 349/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.